CLINICAL_TRIALS
trial_result
· 2014-08-11
Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression [Phase 2]
Summary
The Phase 2 trial of trastuzumab (Herceptin) in metastatic or advanced gastric cancer was terminated, with results posted in August 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-11